Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Sales (2016 - 2025)

Historic Return on Sales for Nutex Health (NUTX) over the last 16 years, with Q3 2025 value amounting to 0.36%.

  • Nutex Health's Return on Sales rose 4500.0% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 3800.0%. This contributed to the annual value of 0.2% for FY2024, which is 3700.0% up from last year.
  • As of Q3 2025, Nutex Health's Return on Sales stood at 0.36%, which was up 4500.0% from 0.07% recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Return on Sales ranged from a high of 0.39% in Q4 2024 and a low of 14.89% during Q3 2022
  • Over the past 5 years, Nutex Health's median Return on Sales value was 0.0% (recorded in 2024), while the average stood at 0.83%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -148900bps in 2022, then soared by 148200bps in 2023.
  • Quarter analysis of 5 years shows Nutex Health's Return on Sales stood at 0.0% in 2021, then tumbled by -56844bps to 0.2% in 2022, then crashed by -100bps to 0.4% in 2023, then skyrocketed by 198bps to 0.39% in 2024, then fell by -7bps to 0.36% in 2025.
  • Its Return on Sales was 0.36% in Q3 2025, compared to 0.07% in Q2 2025 and 0.24% in Q1 2025.